The Allstate Co. (NYSE:ALL – Free Report) – Research analysts at Zacks Research issued their FY2024 earnings estimates for Allstate in a research note issued to investors on Wednesday, November 13th. Zacks Research analyst Z. Masood forecasts that the insurance provider will post earnings per share of $15.42 for the year. The consensus estimate for Allstate’s current full-year earnings is $16.01 per share. Zacks Research also issued estimates for Allstate’s Q2 2025 earnings at $2.94 EPS, Q3 2025 earnings at $3.91 EPS, Q4 2025 earnings at $4.68 EPS, FY2025 earnings at $16.64 EPS, Q1 2026 earnings at $5.19 EPS and Q2 2026 earnings at $3.46 EPS.
A number of other analysts have also recently issued reports on the company. Bank of America increased their price objective on Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a report on Friday, October 18th. UBS Group increased their price target on shares of Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 4th. BMO Capital Markets boosted their price objective on shares of Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Keefe, Bruyette & Woods increased their target price on shares of Allstate from $222.00 to $225.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 6th. Finally, Evercore ISI boosted their price target on shares of Allstate from $191.00 to $195.00 and gave the company an “in-line” rating in a research report on Wednesday, October 9th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $214.19.
Allstate Trading Up 1.6 %
NYSE:ALL opened at $199.97 on Monday. The company has a market cap of $52.95 billion, a P/E ratio of 12.95, a P/E/G ratio of 1.75 and a beta of 0.48. Allstate has a 1 year low of $132.74 and a 1 year high of $201.00. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The stock’s fifty day moving average price is $190.27 and its two-hundred day moving average price is $177.02.
Allstate (NYSE:ALL – Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The company had revenue of $16.63 billion for the quarter, compared to analysts’ expectations of $14.57 billion. During the same period in the prior year, the company posted $0.81 EPS. Allstate’s revenue was up 14.7% compared to the same quarter last year.
Allstate Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be issued a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.84%. The ex-dividend date is Friday, November 29th. Allstate’s payout ratio is currently 23.83%.
Insider Activity
In related news, CEO Thomas J. Wilson sold 90,000 shares of Allstate stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total value of $16,140,600.00. Following the transaction, the chief executive officer now owns 88,552 shares in the company, valued at $15,880,915.68. This trade represents a 50.41 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the sale, the insider now owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. The trade was a 57.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.80% of the company’s stock.
Hedge Funds Weigh In On Allstate
Several institutional investors and hedge funds have recently bought and sold shares of ALL. SPC Financial Inc. lifted its position in Allstate by 3.6% in the third quarter. SPC Financial Inc. now owns 1,564 shares of the insurance provider’s stock valued at $297,000 after purchasing an additional 54 shares during the last quarter. Lake Street Advisors Group LLC raised its holdings in Allstate by 1.8% during the 3rd quarter. Lake Street Advisors Group LLC now owns 3,129 shares of the insurance provider’s stock valued at $596,000 after buying an additional 54 shares during the last quarter. Abacus Planning Group Inc. boosted its position in Allstate by 2.4% during the 3rd quarter. Abacus Planning Group Inc. now owns 2,416 shares of the insurance provider’s stock valued at $458,000 after buying an additional 56 shares during the period. Chicago Partners Investment Group LLC grew its holdings in Allstate by 1.3% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 4,630 shares of the insurance provider’s stock worth $893,000 after acquiring an additional 59 shares during the last quarter. Finally, Carmichael Hill & Associates Inc. grew its holdings in Allstate by 15.0% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 460 shares of the insurance provider’s stock worth $87,000 after acquiring an additional 60 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors.
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
- Five stocks we like better than Allstate
- Election Stocks: How Elections Affect the Stock Market
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Applied Materials Market Capitulates: Now is the Time to Buy
- Where to Find Earnings Call Transcripts
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.